A retrospective sub‐study of perioperative glycaemia and insulin treatment for hospital inpatients at a quaternary centre from the specialist treatment of inpatients: Caring for diabetes in surgery trial ( STOIC ‐D Surgery)
Authors' conclusion
This study characterised perioperative glycaemia trends and suggests that clinicians identify patients who require intensification of insulin treatment in the perioperative period, which needs to be counterbalanced with the risk of hypoglycaemia.
Study context
- Population
- Surgical inpatients with pre-admission diabetes or inpatient hyperglycaemia who underwent at least one procedure during admission; quaternary centre
- Participants
- 518 inpatients
Methodological detailsretrospective sub-study
- Retrospective sub-study
Primary result
As reported in the abstract
day before, day of and day after surgery
Received insulin during the three perioperative days
295
57%
Insulin-receiving patients with a consistent increase in total daily insulin dose across the 3 days
130
44%
Further findings
Baseline HbA1c
- Mean HbA1c
- 52 mmol/mol (6.9%)
Safety
- Hypoglycaemia in all patients, for each perioperative day
- 3%
- Higher in patients receiving perioperative insulin
Original publication
A retrospective sub‐study of perioperative glycaemia and insulin treatment for hospital inpatients at a quaternary centre from the specialist treatment of inpatients: Caring for diabetes in surgery trial ( STOIC ‐D Surgery). Diabet Med. Published 21 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →